Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 01:38 pm IST
Share
Fujian Wanchen Biotechnology Co., Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 116.63 million compared to CNY 103.23 million a year ago. Revenue was CNY 116.63 million compared to CNY 103.23 million a year ago. Net income was CNY 24.32 million compared to CNY 23.2 million a year ago. Basic earnings per share from continuing operations was CNY 0.16 compared to CNY 0.2 a year ago. Diluted earnings per share from continuing operations was CNY 0.16 compared to CNY 0.2 a year ago.
Fujian Wanchen Biotechnology Group Co Ltd, formerly Fujian Wanchen Biotechnology Co Ltd, is a China-based company mainly engaged in the research and development, factory cultivation and sales of fresh edible fungi. The Company's edible fungi products include enoki mushrooms and real shimeji mushrooms such as crab-flavored mushrooms, white jade mushroom and seafood mushrooms. The Company also distributes bacteria residue. The Company mainly distributes its products within domestic market.